Proposed FDA “Conditional Approval”- More Details
Al Musella, DPM, President, Musella Foundation For Brain Tumor Research & Information, Inc., Hewlett, NY. Marty Tenenbaum, PhD, Founder and Chair, Cancer Commons, Los Altos, CA. Q: Your April 5, 2017 blog […]